Comparative Effectiveness of Long Term Fingolimod Versus Glatiramer Acetate on Brain Atrophy Rates, Cognition and Patient Reported Outcomes in Patients With Multiple Sclerosis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Fingolimod (Primary) ; Glatiramer acetate
- Indications Multiple sclerosis
- Focus Adverse reactions
- 25 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 17 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
- 28 Apr 2017 Results (n=120) of preliminary analysis presented at the 69th Annual Meeting of the American Academy of Neurology